Vincent W. Bramwell

2.2k total citations
32 papers, 1.8k citations indexed

About

Vincent W. Bramwell is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Vincent W. Bramwell has authored 32 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 22 papers in Immunology and 10 papers in Infectious Diseases. Recurrent topics in Vincent W. Bramwell's work include Immunotherapy and Immune Responses (19 papers), RNA Interference and Gene Delivery (18 papers) and Immune Response and Inflammation (8 papers). Vincent W. Bramwell is often cited by papers focused on Immunotherapy and Immune Responses (19 papers), RNA Interference and Gene Delivery (18 papers) and Immune Response and Inflammation (8 papers). Vincent W. Bramwell collaborates with scholars based in United Kingdom, Denmark and Mexico. Vincent W. Bramwell's co-authors include Yvonne Perrie, H. Oya Alpar, Daniel Kirby, Afzal R. Mohammed, Dennis Christensen, Satyanarayana Somavarapu, Peter Andersen, Malou Henriksen‐Lacey, Sarah E. McNeil and Kwame N. Atuah and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

Vincent W. Bramwell

32 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent W. Bramwell United Kingdom 22 917 905 426 264 230 32 1.8k
Jonathan A. Meulbroek United States 14 507 0.6× 683 0.8× 623 1.5× 351 1.3× 270 1.2× 17 2.0k
Sue D. Xiang Australia 21 1.0k 1.1× 802 0.9× 193 0.5× 175 0.7× 187 0.8× 44 1.8k
Mildred Ugozzoli United States 29 1.1k 1.2× 801 0.9× 250 0.6× 323 1.2× 509 2.2× 38 1.8k
Jina Kazzaz United States 22 891 1.0× 620 0.7× 239 0.6× 217 0.8× 372 1.6× 29 1.4k
Jay K. Staas United States 16 726 0.8× 699 0.8× 830 1.9× 436 1.7× 395 1.7× 20 2.2k
Vania Manolova Switzerland 16 1.1k 1.2× 738 0.8× 124 0.3× 213 0.8× 243 1.1× 33 2.2k
Mio Mejima Japan 18 490 0.5× 716 0.8× 173 0.4× 348 1.3× 176 0.8× 27 1.6k
Inderjit Jabbal‐Gill United Kingdom 19 560 0.6× 723 0.8× 1.1k 2.5× 176 0.7× 330 1.4× 20 2.0k
Elly van Riet Netherlands 25 704 0.8× 506 0.6× 366 0.9× 386 1.5× 606 2.6× 40 2.1k
Barbara C. Baudner Italy 25 1.1k 1.2× 921 1.0× 315 0.7× 391 1.5× 617 2.7× 46 2.2k

Countries citing papers authored by Vincent W. Bramwell

Since Specialization
Citations

This map shows the geographic impact of Vincent W. Bramwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent W. Bramwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent W. Bramwell more than expected).

Fields of papers citing papers by Vincent W. Bramwell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent W. Bramwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent W. Bramwell. The network helps show where Vincent W. Bramwell may publish in the future.

Co-authorship network of co-authors of Vincent W. Bramwell

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent W. Bramwell. A scholar is included among the top collaborators of Vincent W. Bramwell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent W. Bramwell. Vincent W. Bramwell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kastner, Elisabeth, et al.. (2015). Correlating liposomal adjuvant characteristics to in-vivo cell-mediated immunity using a novel M ycobacterium tuberculosis fusion protein: a multivariate analysis study. Journal of Pharmacy and Pharmacology. 67(3). 450–463. 7 indexed citations
2.
Kaur, Randip, Vincent W. Bramwell, Daniel Kirby, & Yvonne Perrie. (2011). Pegylation of DDA:TDB liposomal adjuvants reduces the vaccine depot effect and alters the Th1/Th2 immune responses. Journal of Controlled Release. 158(1). 72–77. 56 indexed citations
3.
Henriksen‐Lacey, Malou, Vincent W. Bramwell, & Yvonne Perrie. (2010). Radiolabelling of Antigen and Liposomes for Vaccine Biodistribution Studies. Pharmaceutics. 2(2). 91–104. 13 indexed citations
4.
McNeil, Sarah E., A. Vangala, Vincent W. Bramwell, Peter J. Hanson, & Yvonne Perrie. (2010). Lipoplexes Formulation and Optimisation: In Vitro Transfection Studies Reveal No Correlation with In Vivo Vaccination Studies. Current Drug Delivery. 7(2). 175–187. 15 indexed citations
5.
Henriksen‐Lacey, Malou, Dennis Christensen, Vincent W. Bramwell, et al.. (2010). Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. Journal of Controlled Release. 145(2). 102–108. 137 indexed citations
6.
Bhowruth, Veemal, David E. Minnikin, Else Marie Agger, et al.. (2009). Adjuvant properties of a simplified C32 monomycolyl glycerol analogue. Bioorganic & Medicinal Chemistry Letters. 19(7). 2029–2032. 22 indexed citations
7.
Henriksen‐Lacey, Malou, et al.. (2009). Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen. Journal of Controlled Release. 142(2). 180–186. 158 indexed citations
8.
Vangala, A., Vincent W. Bramwell, Shelly McNeil, et al.. (2007). Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. Journal of Controlled Release. 119(1). 102–110. 45 indexed citations
9.
Perrie, Yvonne, Daniel Kirby, Vincent W. Bramwell, & Afzal R. Mohammed. (2007). Recent Developments in Particulate-Based Vaccines. Recent Patents on Drug Delivery & Formulation. 1(2). 117–129. 25 indexed citations
10.
Singh, J. B., et al.. (2006). Diphtheria toxoid loaded poly-(ε-caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods. 38(2). 96–105. 82 indexed citations
11.
Mohammed, Afzal R., Vincent W. Bramwell, Allan G.A. Coombes, & Yvonne Perrie. (2006). Lyophilisation and sterilisation of liposomal vaccines to produce stable and sterile products. Methods. 40(1). 30–38. 72 indexed citations
12.
Bramwell, Vincent W., Jim Eyles, & H. Oya Alpar. (2005). Particulate delivery systems for biodefense subunit vaccines. Advanced Drug Delivery Reviews. 57(9). 1247–1265. 46 indexed citations
13.
Bramwell, Vincent W. & Yvonne Perrie. (2005). The rational design of vaccines. Drug Discovery Today. 10(22). 1527–1534. 38 indexed citations
14.
Bramwell, Vincent W. & Yvonne Perrie. (2005). Particulate Delivery Systems for Vaccines. Critical Reviews in Therapeutic Drug Carrier Systems. 22(2). 151–214. 67 indexed citations
15.
Alpar, H. Oya, Satyanarayana Somavarapu, Kwame N. Atuah, & Vincent W. Bramwell. (2004). Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery. Advanced Drug Delivery Reviews. 57(3). 411–430. 211 indexed citations
16.
Bramwell, Vincent W., et al.. (2003). Adjuvant Action of Melittin Following Intranasal Immunisation with Tetanus and Diphtheria Toxoids. Journal of drug targeting. 11(8-10). 525–530. 25 indexed citations
17.
Somavarapu, Satyanarayana, Vincent W. Bramwell, & H. Oya Alpar. (2003). Oral Plasmid DNA Delivery Systems for Genetic Immunisation. Journal of drug targeting. 11(8-10). 547–553. 11 indexed citations
18.
Alpar, H. Oya & Vincent W. Bramwell. (2002). Current Status of DNA Vaccines and Their Route of Administration;. Critical Reviews in Therapeutic Drug Carrier Systems. 19(4-5). 307–384. 24 indexed citations
19.
Bramwell, Vincent W., Jim Eyles, Satyanarayana Somavarapu, & H. Oya Alpar. (2002). Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen. Immunology. 106(3). 412–418. 20 indexed citations
20.
Eyles, Jim, Vincent W. Bramwell, E. Diane Williamson, & H. Oya Alpar. (2001). Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration. Vaccine. 19(32). 4732–4742. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan A. Meulbroek Breakdown of academic impact, for papers by Sue D. Xiang Breakdown of academic impact, for papers by Mildred Ugozzoli Breakdown of academic impact, for papers by Jina Kazzaz Breakdown of academic impact, for papers by Jay K. Staas Breakdown of academic impact, for papers by Vania Manolova Breakdown of academic impact, for papers by Mio Mejima Breakdown of academic impact, for papers by Inderjit Jabbal‐Gill Breakdown of academic impact, for papers by Elly van Riet Breakdown of academic impact, for papers by Barbara C. Baudner
Rankless by CCL
2026